These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2149459)

  • 1. Cyproterone acetate as monotherapy in prospective randomized trials.
    de Voogt HJ
    Prog Clin Biol Res; 1990; 359():85-91; discussion 105-7. PubMed ID: 2149459
    [No Abstract]   [Full Text] [Related]  

  • 2. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S
    Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of virginal prostatic cancer with cyproterone acetate].
    Maier U
    Z Urol Nephrol; 1985 Apr; 78(4):181-7. PubMed ID: 3160180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ; Pavone-Macaluso M; Smith PH; de Pauw M; Suciu S
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract]   [Full Text] [Related]  

  • 5. Initiation of LHRH monotherapy for prostate cancer.
    Milsted RA
    Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of prostatic cancer with cyproterone acetate].
    Maier U
    Wien Klin Wochenschr; 1988 Jan; 100(1):16-9. PubMed ID: 2964127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of prostatic cancer with cyproterone acetate as monotherapy.
    Beurton D; Grall J; Davody P; Cukier J
    Prog Clin Biol Res; 1987; 243A():369-77. PubMed ID: 2958861
    [No Abstract]   [Full Text] [Related]  

  • 8. The Scandinavian Prostatic Cancer Group.
    Høisaeter PA; Rasmussen F
    Scand J Clin Lab Invest Suppl; 1985; 179():7-11. PubMed ID: 2934797
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyproterone acetate in the management of prostatic cancer.
    Tunn UW
    Prog Clin Biol Res; 1989; 303():105-10. PubMed ID: 2528734
    [No Abstract]   [Full Text] [Related]  

  • 10. Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
    Tunn UW; Goldschmidt AJ; Peter K; Becker M
    Prog Clin Biol Res; 1990; 359():165-76; discussion 177-80. PubMed ID: 2149458
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with cyproterone acetate in a randomised and in an open trial.
    Tunn UW; Weiglein W; Saborowski J; Senge T
    Prog Clin Biol Res; 1987; 243A():365-8. PubMed ID: 2958860
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
    Pavone-Macaluso M; Ingargiola GB; de Voogt H; Viggiano G; Barasolo E; Lardennois B; De Pauw M; Sylvester R
    Prog Clin Biol Res; 1987; 243A():379-82. PubMed ID: 2958862
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].
    Pavone-Macaluso M; Martínez-Piñeiro JA; de Voogt H; Lardennois B; Nasta A; Zolfanelli R; Barasolo E; De Pauw M; Suciu S; Sulvester R
    Arch Esp Urol; 1982; 35(5):304-11. PubMed ID: 6217788
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of symptomatic metastatic prostatic cancer with cyproterone acetate versus orchiectomy: a prospective randomized trial.
    Ostri P; Bonnesen T; Nilsson T; Frimodt-Møller C
    Urol Int; 1991; 46(2):167-71. PubMed ID: 1711250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyproterone acetate and cancer of the prostate. Experience in 46 cases].
    Tauveron I; Hermabessière J
    Therapie; 1988 May; 43(3):175-7. PubMed ID: 2971277
    [No Abstract]   [Full Text] [Related]  

  • 16. The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.
    de Voogt HJ
    Prostate Suppl; 1992; 4():91-5. PubMed ID: 1533452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fatal subfulminant hepatitis caused by cyproterone acetate].
    Antoni M; Bourlière M; Toullec J; Maillot A; Botta-Fridlund D; Gauthier A
    Gastroenterol Clin Biol; 1991; 15(10):772-3. PubMed ID: 1840042
    [No Abstract]   [Full Text] [Related]  

  • 18. Gestagens in the management of prostatic carcinoma.
    Szendröi Z
    Int Urol Nephrol; 1984; 16(4):327-35. PubMed ID: 6100181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal therapy of advanced prostatic cancer.
    Fair WR
    J Urol; 1986 Sep; 136(3):653-4. PubMed ID: 2942708
    [No Abstract]   [Full Text] [Related]  

  • 20. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.